WallStreetZenWallStreetZen

NASDAQ: CYTH
Cyclo Therapeutics Inc Earnings & Revenue

CYTH past revenue growth

How has CYTH's revenue growth performed historically?
Company
-21.76%
Industry
9.72%
Market
17.84%
CYTH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CYTH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CYTH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CYTH earnings and revenue history

Current Revenue
$1.1M
Current Earnings
-$20.1M
Current Profit Margin
-1,863.4%

CYTH Return on Equity

Current Company
-4,505.7%
Current Industry
15.5%
Current Market
188%
CYTH's Return on Equity (-4,505.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CYTH announces earnings.

CYTH Return on Assets

Current Company
-290.8%
Current Industry
3.4%
CYTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CYTH Return on Capital Employed

Current Company
-419.65%
Current Industry
5.1%
CYTH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CYTH vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CYTH$1.08M-$20.04M-$20.06M+1.25%N/A
DRRX$8.55M-$24.80M-$27.62M-10.96%N/A
BGXX$0.00-$8.92M-$9.57MN/AN/A
RMTI$83.61M-$2.68M-$8.44M+5.69%N/A
HUGE$0.00-$13.85M-$16.42MN/AN/A

CYTH earnings dates

Next earnings date
May 13, 2024

Cyclo Therapeutics Earnings & Revenue FAQ

What were CYTH's earnings last quarter?

On Invalid Date, Cyclo Therapeutics (NASDAQ: CYTH) reported Q4 2023 earnings per share (EPS) of -$0.23, up 61.02% year over year. Total Cyclo Therapeutics earnings for the quarter were -$5.64 million. In the same quarter last year, Cyclo Therapeutics's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Cyclo Therapeutics stock.

What was CYTH's earnings growth in the past year?

As of Q1 2024, Cyclo Therapeutics's earnings has grown year over year. Cyclo Therapeutics's earnings in the past year totalled -$20.06 million.

What is CYTH's earnings date?

Cyclo Therapeutics's earnings date is Invalid Date. Add CYTH to your watchlist to be reminded of CYTH's next earnings announcement.

What was CYTH's revenue last quarter?

On Invalid Date, Cyclo Therapeutics (NASDAQ: CYTH) reported Q4 2023 revenue of $311.40 thousand up 66.7% year over year. In the same quarter last year, Cyclo Therapeutics's revenue was $186.80 thousand.

What was CYTH's revenue growth in the past year?

As of Q1 2024, Cyclo Therapeutics's revenue has grown -21.76% year over year. This is 31.48 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.72%. Cyclo Therapeutics's revenue in the past year totalled $1.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.